Inhibitor‐induced dimerization mediates lufotrelvir resistance in mutants of SARS‐CoV‐2 3C‐like protease
Open Access
- 25 August 2025
- journal article
- Published by Wiley in Protein Science
- Vol. 34 (9) , e70275
Abstract
The emergence of SARS‐CoV‐2 and other lethal coronaviruses has prompted extensive research into targeted antiviral treatments, particularly focusing on the viral 3C‐like protease (3CLpro) due to its essential role for viral replication. However, the rise of drug resistance mutations poses threats to public health and underscores the need to predict resistance mutations and understand the mechanism of how these mutations confer resistance. The binding of inhibitor to 3CLpro drives it from the monomeric to the active dimeric form, which can counterintuitively lead to enzyme activation rather than inhibition. Furthermore, we find this allosteric coupling between binding and dimerization is sensitive to mutation, leading to a new mechanism for drug resistance. Understanding the relationship between inhibitor binding and dimerization is important for resistant strain surveillance and development of robust antivirals. Herein, we present a systematic study of drug resistance mediated by inhibitor‐induced dimerization of 3CLpro.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (327028‐09)
- Canadian Institutes of Health Research (MOP‐13694, OV3‐170644)
This publication has 78 references indexed in Scilit:
- Mechanisms and enzymes involved in SARS coronavirus genome expressionJournal of General Virology, 2003
- Quantitative Determination of Noncovalent Binding Interactions Using Automated Nanoelectrospray Mass SpectrometryAnalytical Chemistry, 2003
- Coronavirus as a possible cause of severe acute respiratory syndromeThe Lancet, 2003
- Virus-encoded proteinases and proteolytic processing in the NidoviralesJournal of General Virology, 2000
- Drug resistance mutations can affect dimer stability of HIV‐1 protease at neutral pHProtein Science, 1999
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Occurrence and frequency of coronavirus infections in humans as determined by enzyme-linked immunosorbent assayInfection and Immunity, 1982
- The coronaviruses.1975
- Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitorsBiochimica et Biophysica Acta (BBA) - Enzymology, 1969
- Comparison of Experimental Binding Data and Theoretical Models in Proteins Containing Subunits*Biochemistry, 1966